Preparation and application of phellinus igniarius polyphenol and lipidosome thereof
Preparation of mulberry polyphenol liposomes through ultrasonic extraction and high-pressure homogenization method has solved the problem of low extraction efficiency of mulberry polyphenols, improved its bioavailability and anti-tumor activity, and realized mulberry polyphenols in anti-tumor drugs efficient use.
Patent Information
- Application Number
- CN202410986985.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-23
- Publication Date
- 2024-11-08
AI Technical Summary
The existing mulberry yellow polyphenol extraction methods are inefficient, resulting in low bioavailability, limiting their development and application in anti-tumor and other applications.
The combination of ultrasonic extraction and high-pressure homogenization method was used to prepare mulberry yellow polyphenol liposomes with uniform particle size and high encapsulation rate, which extended the half-life of mulberry yellow polyphenol and improved its bioavailability.
It significantly improves the bioavailability and anti-tumor activity of mulberry yellow polyphenols, extends its half-life, and achieves efficient drug utilization, enhancing its effect in anti-tumor, antioxidant and anti-inflammatory drugs.
Smart Images

Figure CN118903223A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of deep processing of mulberry linterus, and specifically relates to a preparation method and application of mulberry linterus polyphenols and liposomes thereof. Background Art
[0002] Phellinus igniarius is a traditional Chinese medicine, also known as monkey eyes, mulberry ears, and needle-layer fungus. It belongs to the phylum Basidiomycetes, class Hymenomycetes, order Polyporaceae, and family Polyporaceae. Its fruiting body is used as medicine. It is a fungus that grows on mulberry trees. Phellinus igniarius has extremely high medicinal value. Wild Phellinus igniarius fruiting bodies grow slowly and are rare. In recent years, with the development of cultivation technology, Phellinus igniarius has been cultivated on a large scale in many regions of my country.
[0003] At present, people have studied and analyzed the components and pharmacological effects of Phellinus igniarius, and found that Phellinus igniarius contains multiple active ingredients such as polysaccharides, agaric acid, fatty acids, sterols, triterpenes, aromatic acids, amino acids, enzymes and flavonoids. Among them, Phellinus igniarius polyphenols are a class of small molecule active substances in Phellinus igniarius, which have great potential for the development of anti-tumor drugs and have been reported to have anti-breast cancer, lung cancer, liver cancer and other activities. Past studies have shown that polyphenols have a short half-life in the body, are eliminated very quickly, and have low bioavailability, which greatly limits the biological activity of polyphenols such as Phellinus igniarius and their related applications. As one of the main active substances in Phellinus igniarius, polyphenol compounds have multiple biological activities, but their low bioavailability is not conducive to development and utilization. There is still a lack of relevant research on how to improve the bioavailability of Phellinus igniarius polyphenols.
[0004] Existing studies have shown that the active substance composition of mulberry linteopolyphenols varies in solvents of different polarities, which directly affects the biological activity of mulberry linteopolyphenols. However, the preparation of mulberry linteopolyphenols is currently mostly extracted using ethanol as a solvent, and the method has a low degree of purification, and it is not possible to effectively obtain a mulberry linteopolyphenol extract with high biological activity, which limits its further application. Therefore, how to provide a method for extracting mulberry linteopolyphenols with high activity and high precision has become a problem to be solved in the field. Summary of the invention
[0005] The object of the present invention is to provide a preparation method and application of mulberry ignia polyphenol and its liposome. The mulberry ignia polyphenol liposome prepared by the preparation method provided by the present invention not only has the advantages of uniform particle size and high encapsulation rate, but also can effectively prolong the half-life of mulberry ignia polyphenol, improve the bioavailability of mulberry ignia polyphenol, and realize the efficient utilization of mulberry ignia polyphenol.
[0006] In order to achieve the above object, the present invention provides the following technical solutions:
[0007] The present invention provides a method for preparing mulberry linterus polyphenols, comprising the following steps:
[0008] The fruiting bodies of Phellinus linteus were crushed, the obtained powder was mixed with an alcohol solution, ultrasonically extracted and centrifuged, and the supernatant was collected;
[0009] removing the alcohol solution from the supernatant, and freeze-drying the supernatant after removing the alcohol solution to obtain the alcohol extract of Phellinus linteus fruiting body;
[0010] Mixing and dissolving the ethanol extract of Phellinus linteus fruiting bodies with a volume fraction of 20% ethanol solution to obtain a suspension;
[0011] Extracting the suspension with an organic reagent, collecting the extract to obtain a mixed extract;
[0012] The organic reagent in the mixed extract is removed to obtain the mulberry linterus polyphenol extract.
[0013] Furthermore, the alcohol solution is ethanol, the volume fraction of the ethanol is 60%, the solid-liquid ratio of the powder to the ethanol is 1 g:20 mL; and the power of the ultrasonic extraction is 600W.
[0014] Furthermore, the organic reagent includes petroleum ether, chloroform and ethyl acetate.
[0015] The present invention also provides a method for preparing mulberry linterus polyphenol liposomes, which comprises the following steps:
[0016] Mixing the mulberry linseed polyphenols, cholesterol, soybean lecithin and an organic solvent to obtain a mixed solution;
[0017] Recovering the organic solvent in the mixed solution to form a thin film of the remaining solution;
[0018] Adding PBS solution to the film to obtain a light yellow aqueous solution;
[0019] The light yellow aqueous solution is homogenized at room temperature and high pressure for 5 to 10 minutes to obtain the mulberry linterus polyphenol liposome.
[0020] Furthermore, the mass ratio of mulberry ignia polyphenol, cholesterol and soybean lecithin is 5-10:30-50:1-5, the concentration of soybean lecithin is 20 mg / mL, the concentration of mulberry ignia polyphenol is 2 mg / mL, and the concentration of cholesterol is 2.5 mg / mL.
[0021] Furthermore, the organic solvent is one or more of anhydrous ethanol, ether and chloroform, and the solid-liquid ratio of the total mass of the mulberry ignia polyphenols, cholesterol and soybean lecithin to the organic solvent is 1g:10-50mL.
[0022] Furthermore, the material-liquid ratio of the PBS solution to the film is 1 g: 10-50 mL;
[0023] After the PBS solution is added to the film, the film is further dispersed by rotation and ultrasound;
[0024] The temperature of the rotation is 40° C., the time of the ultrasonic dispersion is 30 min; and the pressure of the high-pressure homogenization is 1200 MPa.
[0025] The present invention also provides a mulberry linterus polyphenol liposome, which is obtained by any of the preparation methods described above.
[0026] The present invention also provides a method for preserving the mulberry linoleum polyphenol liposomes as described above, wherein the mulberry linoleum polyphenol liposomes are stored at 4-25° C. in the dark.
[0027] The present invention also provides a method for preparing any of the above-mentioned mulberry linden polyphenols, a method for preparing mulberry linden polyphenol liposomes, and the use of mulberry linden polyphenol liposomes or a method for preserving the mulberry linden polyphenols in the preparation of one or more of anti-tumor drugs, antioxidant drugs and anti-inflammatory drugs.
[0028] Beneficial effects of the present invention:
[0029] The present invention provides a method for preparing mulberry linterus polyphenols and liposomes thereof. The present invention obtains mulberry linterus polyphenols containing more active ingredients by extraction with different solvents. Compared with mulberry linterus polyphenols prepared by the method of the present invention, the anti-tumor activity is better.
[0030] The present invention also adopts a thin film dispersion method combined with ultrasound and high-pressure homogenization method for processing, which has the advantages of stable preparation process, uniform particle size of mulberry linoleic acid liposomes, high encapsulation rate, and no ethanol residue. The encapsulation rate of mulberry linoleic acid liposomes prepared by the present application can be as high as 86.01±1.83%, and the use of the method of preparing mulberry linoleic acid into liposomes can significantly improve the bioavailability of mulberry linoleic acid and prolong its half-life. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required to be used in the embodiments are briefly introduced below.
[0032] Figure 1 The effects of different components of Morinda nitrosa polyphenols (PV1-PV5) on the growth of HepG2 and L-O2 cells in Experimental Example 1;
[0033] (a) shows the growth inhibition effect of PV1-PV5 on HepG2 cells; (b) shows the growth inhibition effect of PV1-PV5 on normal liver cells L-O2;
[0034] Figure 2 To characterize and identify the components of Morinda nitrosa polyphenol PV5 in Experimental Example 2;
[0035] Wherein (a) is the HPLC characterization of Phellinus igniarius polyphenol PV5; (b) is the identification of the components of Phellinus igniarius polyphenol PV5 by UPLC-Q-TOF-MS;
[0036] Figure 3 The effect of different storage temperatures on the retention rate of mulberry linoleic acid polyphenols and mulberry linoleic acid polyphenols liposomes in Experimental Example 4;
[0037] Among them, (a) shows the change of retention rate of mulberry linoleic acid polyphenol and mulberry linoleic acid polyphenol liposome under room temperature (25°C) for 50 days; (b) shows the change of retention rate of mulberry linoleic acid polyphenol and mulberry linoleic acid polyphenol liposome under low temperature (4°C) for 50 days;
[0038] Figure 4 The schematic diagram and transmission electron microscope image of the appearance of the mulberry linterus polyphenol liposome prepared by the present invention in Experimental Example 1;
[0039] Among them, (a) is a schematic diagram of the appearance of mulberry linoleic acid liposomes; (b) is a transmission electron microscopy image;
[0040] Figure 5 Schematic diagram of the release characteristics of mulberry linterus polyphenol liposomes in the simulated stomach and intestine in Experimental Example 2;
[0041] Figure 6 Schematic diagram of the process of simulating the absorption of mulberry linterus polyphenol liposomes in vivo in Experimental Example 3;
[0042] Figure 7 Schematic diagram of blood drug concentration and tissue distribution in Experimental Example 4;
[0043] Among them, (a) is the distribution change of mulberry linoleic acid polyphenol in tissues over time after mice were gavaged with fluorescently labeled mulberry linoleic acid liposomes; (b) is the AUC value of mulberry linoleic acid polyphenol in various tissues; (c) is a schematic diagram of the change of drug content in blood over time after mice were gavaged with fluorescently labeled mulberry linoleic acid polyphenol liposomes;
[0044] Figure 8 This is a schematic diagram of the growth curve of mouse body weight and tumor size in Experimental Example 5;
[0045] Among them, (a) is the mouse tumor tissue image; (b) is the mouse weight change curve; (c) is the mouse tumor weight change curve; (d) is the tumor volume growth curve;
[0046] Fig. 9 Schematic diagram of the effect of mulberry linterus polyphenol liposomes on the pathological morphology of tumor tissue and liver function-related indicators in H22 tumor-bearing mice in Experimental Example 5
[0047] Among them, (a) is HE staining of tumor tissue; (b) is the necrotic area in HE staining; (c) is the GSH and MDA content in serum; (d) is the GOT content in serum; (e) is the GPT content in serum;
[0048] Fig.10 This is a schematic diagram of the effect of mulberry linterus polyphenol liposomes on the expression of apoptosis-related genes in tumor tissue of H22 tumor-bearing mice in Experimental Example 5;
[0049] Among them, (a) to (d) are schematic diagrams of the effects of mulberry linalool liposomes on the expression levels of Caspase-3, Caspase-8, Caspase-9, and Bax;
[0050] Fig.11 The effect of mulberry linterus polyphenol liposomes on the expression level of MEK / ERK-related pathway proteins in tumor tissues of H22 tumor-bearing mice in Experimental Example 5;
[0051] Among them, (a) is a schematic diagram of the results of microscopic observation of tumor sections; (b) is a schematic diagram of the effects of different treatments on the protein expressions of ERBB1, ERBB2, P-MEK, and P-ERK. DETAILED DESCRIPTION
[0052] The present invention provides a method for preparing mulberry linterus polyphenols, comprising the following steps:
[0053] The mulberry linterus fruiting bodies are crushed, the obtained powder is mixed with an alcohol solution, and the mixture is subjected to ultrasonic extraction and centrifugation to collect the supernatant; the alcohol solution in the supernatant is removed, and the supernatant after the alcohol solution is removed is freeze-dried to obtain the mulberry linterus fruiting body alcohol extract; the mulberry linterus fruiting body alcohol extract is mixed and dissolved with a 20% by volume ethanol solution to obtain a suspension; the suspension is extracted with an organic reagent, and the extract is collected to obtain a mixed extract; the organic reagent in the mixed extract is removed to obtain the mulberry linterus polyphenols.
[0054] The present invention crushes Phellinus linteus fruiting bodies, mixes the obtained powder with an alcohol solution, performs ultrasonic extraction and centrifugation, and collects the supernatant and precipitate. The alcohol solution of the present invention is preferably ethanol, more preferably 60% ethanol by volume. The solid-liquid ratio of the powder of the present invention to the alcohol solution is preferably 1g:20mL.
[0055] The power of the ultrasound in the present invention is preferably 600 W, and the time is preferably 2 h. The speed of the centrifugation in the present invention is preferably 14309 g, and the time is preferably 30 min.
[0056] After obtaining the supernatant and the precipitate, the present invention separates the supernatant from the precipitate, extracts the precipitate once repeatedly according to the above process, and combines the supernatants extracted twice.
[0057] After obtaining the combined supernatant, the present invention removes the alcohol solution in the combined supernatant. The present invention preferably uses rotary evaporation to evaporate the alcohol solution. The processing condition of the rotary evaporation is preferably 120 MPa. The supernatant after removing ethanol is freeze-dried to obtain the alcohol extract of Phellinus linteus fruiting body.
[0058] After obtaining the alcohol extract of Phellinus linteus fruiting bodies, the present invention mixes and dissolves the alcohol extract of Phellinus linteus fruiting bodies with 20% ethanol by volume to obtain a suspension; the present invention preferably has a solid-liquid ratio of the alcohol extract of Phellinus linteus fruiting bodies to 20% ethanol of 1:5-20.
[0059] After obtaining the suspension, the present invention sequentially extracts the suspension twice with equal volumes of organic reagents, and combines the extracts to obtain a mixed extract.
[0060] The organic solvent of the present invention preferably includes petroleum ether, chloroform and ethyl acetate, and it is more preferred to use the above organic solvents to treat the suspension in sequence; further preferably, the dissolved mulberry linterinary fruit body alcohol extract solution is extracted twice with an equal volume of petroleum ether, and the extracts are combined to obtain a first mixed solution; the first mixed solution is then extracted twice with an equal volume of chloroform, and the extracts are combined to obtain a second mixed solution; finally, the second mixed solution is extracted twice with an equal volume of ethyl acetate, and the extracts are combined to obtain a final mixed extract.
[0061] After obtaining the final mixed extract, the present invention removes the organic reagent in the mixed extract to obtain the mulberry linterus polyphenols.
[0062] The method for removing the organic solvent from the mixed extract of the present invention is preferably a rotary evaporation method.
[0063] The present invention also provides a method for preparing mulberry linoleic acid polyphenol liposomes, comprising the following steps:
[0064] The mulberry linterus polyphenols prepared by the above method are mixed and dissolved completely with cholesterol, soybean lecithin and an organic solvent to obtain a mixed solution;
[0065] Recovering the organic solvent in the mixed solution to form a thin film of the remaining solution;
[0066] Adding PBS solution to the film to obtain a light yellow aqueous solution;
[0067] The light yellow aqueous solution was homogenized at room temperature and high pressure for 5 minutes to obtain the mulberry linalool liposome.
[0068] The present application mixes mulberry polyphenols, cholesterol, soybean lecithin and an organic solvent to obtain a mixed solution. The weight ratio of mulberry polyphenols, cholesterol and soybean lecithin is preferably 5-10:30-50:1-5, more preferably 8:48:1; the organic solvent of the present invention preferably includes one or more of anhydrous ethanol, ether and chloroform, further preferably anhydrous ethanol, ether or chloroform, more preferably anhydrous ethanol. The volume ratio of the mixture of mulberry polyphenols, cholesterol and soybean lecithin to the organic solvent is preferably 1:10-50, more preferably 1:20.
[0069] After obtaining the mixed solution, the present invention recovers the solution in the mixed solution to form a film of the remaining solution. The present invention preferably uses rotary evaporation to recover the organic solvent, and the rotary evaporation pressure is preferably 120 MPa, the temperature is preferably ≤40°C, and the time is preferably 30 min.
[0070] After obtaining the film, the present invention adds PBS solution to the film to completely disperse the film in the PBS solution to obtain a light yellow aqueous solution. The present invention preferably hydrates the film and PBS mixture under rotating conditions to form a relatively uniform liposome suspension, and then uses ultrasonic dispersion. The rotary evaporation pressure is preferably 120MPa, the temperature is preferably 40°C, and the time is preferably 30min; the ultrasonic dispersion time is preferably 30min.
[0071] After obtaining the light yellow aqueous solution, the present invention homogenizes the light yellow aqueous solution at room temperature and high pressure for 5 minutes to obtain the mulberry linterinary polyphenol liposome. The pressure of the high pressure homogenization in the present invention is preferably 1200 MPa, and the time is preferably 5 minutes.
[0072] After obtaining the above extract, remove the organic reagent in the mixed extract to obtain the mulberry linterus polyphenol extract. In the present invention, preferably, the organic reagent in the combined extract is removed by rotary evaporation under reduced pressure to obtain the mulberry linterus polyphenol extract. The pressure of the reduced pressure removal in the present invention is preferably 120 MPa.
[0073] The present invention also provides a mulberry linoleic acid liposome, which is obtained by the above-mentioned preparation method. The particle size of the mulberry linoleic acid liposome preferably prepared by the present invention is 90-120 nm.
[0074] The present invention also provides the use of the above-mentioned mulberry linterus polyphenol liposomes in the preparation of anti-tumor drugs, antioxidant drugs, and anti-inflammatory drugs. The mulberry linterus polyphenol liposomes of the present application have the advantages of uniform particle size, high encapsulation rate, and no ethanol residue, and have high biological activity and high bioavailability. The method of the present application can significantly improve the therapeutic effect of mulberry linterus polyphenols on tumors.
[0075] The present invention also provides a method for preserving the mulberry linoleum polyphenol liposomes, wherein the mulberry linoleum polyphenol liposomes are stored at 4-25°C.
[0076] The present invention is more preferably stored at 4° C. Low temperature storage at 4° C. is beneficial to inhibiting the degradation rate of mulberry linterus polyphenol liposomes, and the retention rate within 50 days can reach 62.49±2.86%.
[0077] In order to further illustrate the present invention, the preparation method and application of the mulberry linolenic acid polyphenol liposome provided by the present invention are described in detail below in combination with the accompanying drawings and examples, but they should not be construed as limiting the scope of protection of the present invention.
[0078] This application uses the determination method in the "Notice of the Zhejiang Provincial Food and Drug Administration on the promulgation of the standards for Chinese medicinal materials and the processing specifications for medicinal pieces of Phellinus versicolor" to determine the total phenol content in the drug.
[0079] Example 1 Preparation of Morinda nitida polyphenols
[0080] The fruiting bodies of Phellinus igniarius were crushed into coarse powder, and 60% ethanol was added at a solid-liquid ratio of 1g:20mL. The mixture was placed in an ultrasonic pool for ultrasonic (600W) extraction for 2h, centrifuged at 14309g for 30min, and the supernatant was collected. The precipitate was extracted once according to the above process, and the supernatant was combined. The ethanol was evaporated cleanly by a rotary evaporator and then freeze-dried to obtain the alcohol extract of Phellinus igniarius fruiting bodies. 60g of the freeze-dried alcohol extract was taken and dissolved in 20% ethanol by volume. The suspension was extracted twice with equal volumes of petroleum ether, chloroform, and ethyl acetate organic reagents, and the extracts were combined. The organic reagents of each part were removed under reduced pressure by a rotary evaporator to obtain the extract of Phellinus igniarius polyphenols. After silica gel column chromatography and thin layer chromatography, 5 components (PV1, PV2, PV3, PV4, and PV5) were obtained.
[0081] Test Example 1 Screening of Phellinus linteus polyphenol components
[0082] HepG-2 liver cancer cells and normal liver cells L-O2 were prepared into cell suspensions, with 900 μL (1×10 5 After culturing at 37°C for 24 hours, 100 μL of the sample to be tested was added (the final concentration of the sample group was 6.25, 12.5, 25, 50, and 100 μg / mL). The blank control group was DMSO. After culturing at 37°C and 5% CO2 for 48 hours, the cell apoptosis was determined using the AlamarBlue cell proliferation detection reagent. The results are shown in the figure. Figure 1 As shown in (a).
[0083] Depend on Figure 1As shown in (a), PV1, PV2, PV3, PV4, and PV5 showed different degrees of inhibitory effects on the proliferation of liver cancer cells HepG-2, especially PV1 and PV5 had better effects. Figure 1 As shown in (b), PV1 has a significant inhibitory effect on the proliferation of normal hepatocytes, while PV5 shows no cytotoxicity. In summary, PV5 has a unique effect of inhibiting the growth of HepG2 hepatoma cells and has no significant cytotoxicity to normal hepatocytes.
[0084] Experimental Example 2 Component Analysis of Phellinus Immaturus Polyphenols PV5
[0085] PV5 was characterized and its components were identified by HPLC and UPLC-Q-TOF-MS. The experimental conditions were as follows: the chromatographic column was Waters BEH C 18 (100mm×2.1mm, 1.7μm); mobile phase A is water, phase B is acetonitrile, and the linear gradient elution process is as follows: 95% A (0-2min), 95%-0% A (2-50min), 0% A (50-55min), 0%-95% A (55-55.1min), 95% A (55.1-60min); flow rate is 0.3mL / min; injection volume is 10μL; column temperature is 40℃. MS conditions: ESI-ion source, mass scanning range mass-to-charge ratio (m / z) 50-1500Da, scanning mode is negative ion mode, capillary voltage is 2.8kV, sample cone voltage is 80V, extraction cone voltage is 4V, source temperature is 120℃, desolvation temperature is 300℃, cone gas is 50L / h, and desolvation gas flow rate is 600L / h. The identification results are as follows Figure 2 and Table 1, according to Figure 2 As shown in Table 1, 32 components were identified from PV5.
[0086] Table 1 Polyphenol compounds in PV5
[0087]
[0088]
[0089] Example 2 A method for preparing mulberry linterus polyphenol liposomes
[0090] Add the mulberry ignia polyphenol (PV5), cholesterol and soybean lecithin obtained in Example 1 to a 250 mL eggplant-shaped bottle, dissolve them in 10 mL of anhydrous ethanol, and then use a rotary evaporator to reduce pressure and recover the ethanol, keeping the evaporation temperature no more than 40°C. After evaporation, a uniform film is formed in the eggplant-shaped bottle. Inject 50 mL of PBS buffer into the eggplant-shaped bottle and rotate slowly at 40°C for 30 minutes. Then perform ultrasonic dispersion for 30 minutes to finally obtain a uniform light yellow aqueous solution, and obtain mulberry ignia polyphenol liposomes after room temperature and high pressure homogenization (1200 MPa, 5 minutes).
[0091] Test Example 3: Raw material ratio optimization test
[0092] In order to better prepare mulberry linoleic acid liposomes, the present invention conducted an effect verification test on the effects of the ratio of cholesterol to soybean lecithin and the ratio of mulberry linoleic acid to soybean lecithin on the particle size, potential and encapsulation efficiency of mulberry linoleic acid liposomes. The verification process and results are shown below.
[0093] The inhibitory effect of mulberry linterus polyphenol liposome on HepG2 cells was verified by the following methods:
[0094] In a 96-well plate, 100 μL of HepG2 cell suspension (1×10 4 The cells were divided into a control group and a mulberry linoleic acid liposome intervention group. After the cells adhered to the wall, the control group was replaced with 100 μL of IPMI-1640 medium containing 10% fetal bovine serum, and the mulberry linoleic acid liposome intervention group was replaced with 100 μL of complete medium containing 50, 100 and 200 μg / mL, respectively, and cultured for 48 hours. The cell survival rate was determined according to the instructions of the AlamarBlue cell proliferation detection reagent.
[0095] The mulberry linoleic acid liposomes were diluted with ultrapure water until they were colorless, with a dilution ratio of 1:1000. The particle size and Zeta potential of the samples were measured using a NanoBrook 90 Plus PALS nanoparticle size Zeta potential instrument. Each sample was run in parallel for three times, and the results are shown in Tables 2 and 3.
[0096] (1) Verification of the effect of the ratio of cholesterol to soybean lecithin on liposome particle size, potential and encapsulation efficiency:
[0097] The concentration of mulberry linoleic acid was fixed at 2 mg / mL, the concentration of soybean lecithin was fixed at 20 mg / mL, 1 mL of soybean lecithin and 1 mL of cholesterol were taken respectively, and mulberry linoleic acid liposomes were prepared according to the mass ratio of cholesterol: soybean lecithin of 1:4, 1:6, 1:8, 1:10, and 1:20, and the other parameters and preparation method were as in Example 1. The particle size, potential, encapsulation efficiency and in vitro inhibitory activity of the prepared mulberry linoleic acid liposomes on liver cancer cells were measured, and the results are shown in Table 2.
[0098] Table 2 Effects of cholesterol and soybean lecithin content on liposome properties and antitumor activity
[0099]
[0100] Note: Different lowercase letters in the same row indicate significant differences (P<0.05).
[0101] According to Table 1, when the mass ratio of cholesterol to soybean lecithin is 1:8, the encapsulation rate is the highest, the particle size is the smallest, and the inhibition rate of H22 cells at 100μg / mL and 200μg / mL reaches the highest; when the mass ratio of cholesterol to soybean lecithin is 1:6, the inhibition rate of HepG2 cells at 50μg / mL reaches the highest. In summary, when the mass ratio of cholesterol to soybean lecithin is 1:6-8, the liposome properties are better and the anti-tumor activity is higher.
[0102] (2) Verification of the effect of the ratio of mulberry linoleic acid polyphenols to soybean lecithin on liposome particle size, potential and encapsulation efficiency:
[0103] The concentration of soybean lecithin was fixed at 20 mg / mL, the concentration of cholesterol was 2.5 mg / mL, and the mass ratio of cholesterol to soybean lecithin was 1:8. Subsequently, mulberry ignia polyphenol liposomes were prepared according to the mass ratios of mulberry ignia polyphenol to soybean lecithin of 1:4, 1:6, 1:8, 1:10, and 1:20, respectively. The particle size, potential, encapsulation efficiency and in vitro inhibitory activity of the prepared mulberry ignia polyphenol liposomes on liver cancer cells were measured. The results are shown in Table 3.
[0104] Table 3 Effect of mulberry linterus polyphenol content on liposome properties and antitumor activity
[0105]
[0106] Note: Different lowercase letters in the same row indicate significant differences (P<0.05).
[0107] According to Table 3, when the ratio of mulberry polyphenols to soybean lecithin is 1:20, the encapsulation efficiency of the liposome is optimal, reaching 86.01±1.83%; when the mass ratio of mulberry polyphenols to soybean lecithin is 1:6, the mulberry polyphenol liposomes prepared have the smallest particle size and the best anti-liver cancer activity, and show good stability; considering the encapsulation efficiency, potential value, particle size and anti-tumor activity of mulberry polyphenol liposomes, the mulberry polyphenol liposomes are prepared with a ratio of mulberry polyphenols to soybean lecithin of 1:5-10.
[0108] In summary, the mass ratio of cholesterol: soybean lecithin: mulberry linterus polyphenols is 5-10:30-50:1-5 to prepare mulberry linterus polyphenols liposomes. The mulberry linterus polyphenols liposomes prepared within this ratio have the advantages of high encapsulation rate, small particle size and high anti-tumor activity.
[0109] Test Example 4 Evaluation of Storage Stability of Phellinus Immature Polyphenol Liposomes
[0110] The mulberry linoleic acid liposomes prepared according to the technical scheme of Example 1 were stored at room temperature (25°C) and low temperature (4°C) in the dark. The mulberry linoleic acid was dispersed in water as a control group. All samples were placed in sealed glass bottles, and each sample was paralleled with 3 samples. The mulberry linoleic acid content was adjusted to 100 μg / mL. Samples were taken at 0, 5, 10, 15, 20, 25, 30, 35, 40, 45 and 50 days, and the total phenol content was determined. The results are as follows: Figure 3 shown.
[0111] Depend on Figure 3 As shown in (a), at room temperature (25°C), the retention rates of mulberry linoleic acid polyphenol and mulberry linoleic acid polyphenol liposome after storage for 50 days were 30.23±2.23% and 51.71±3.71%, respectively. The experimental results show that liposomes have a good improvement on the storage stability of mulberry linoleic acid polyphenol. Figure 3 As shown in (b), under low temperature conditions (4°C), the retention rates of mulberry linoleic acid polyphenol and mulberry linoleic acid polyphenol liposome after storage for 50 days were 38.06±3.53% and 62.49±2.86%, respectively. In summary, the degradation rate of mulberry linoleic acid polyphenol liposome under low temperature conditions is significantly lower than that under normal temperature conditions, and low temperature conditions also have a good improvement on the degradation rate of mulberry linoleic acid polyphenol, but under normal temperature conditions, mulberry linoleic acid polyphenol liposome still has a good retention rate. Therefore, mulberry linoleic acid polyphenol liposome can be well preserved under 4-25°C conditions, and the preservation effect of mulberry linoleic acid polyphenol liposome at 4°C is better.
[0112] Experimental Example 1 Characterization and determination of mulberry linterus polyphenol liposomes
[0113] The characterization test of the mulberry linoleic acid polyphenol liposomes prepared by the method described in Example 1 was performed, and the test method and results are as follows:
[0114] The present invention adopts the centrifugation method to determine the encapsulation efficiency of mulberry linoleic acid liposomes, and the specific operation is as follows:
[0115] Accurately measure 1 mL of mulberry linoleic acid liposomes (1 mg / mL), dilute the mulberry linoleic acid liposomes to 10 mL with methanol, and then perform ultrasonic demulsification for 5 minutes to measure the total content of mulberry linoleic acid (Wtotal);
[0116] Then accurately measure 1 mL of mulberry linterus polyphenol liposomes, centrifuge at 10000 r / min for 30 min, take the supernatant, and determine the total phenol content in the sample according to the determination method in the "Notice of Zhejiang Provincial Food and Drug Administration on the promulgation of mulberry linterus Chinese medicinal material standards and decoction preparation specifications", and measure the free mulberry linterus polyphenol content (Wyou);
[0117] The mulberry linoleic acid liposomes are placed in a container, and the mulberry linoleic acid liposomes have an appearance as follows: Figure 4 As shown in (a), it is a clear light yellow liquid; then the mulberry linterinary phenol liposomes were diluted 100 times with ultrapure water, the sample solution was added dropwise to the electron microscope sample copper grid, the excess liposomes were absorbed with filter paper, 2% phosphotungstic acid solution was added dropwise for dyeing, the excess dye was absorbed with filter paper, and the liposomes were observed for appearance with a field emission transmission electron microscope (TEM-EDS). The results are shown in FIG. Figure 4 As shown in (b), it can be observed that the liposomes are spherical, well dispersed, and have uniform particle size distribution.
[0118] Experimental Example 2 Evaluation of Digestive Stability of Phellinus Immature Polyphenol Liposomes
[0119] The digestion stability of the mulberry linoleic acid polyphenol liposomes prepared in Example 1 was verified by an in vitro digestion simulation method, and the specific operation was as follows:
[0120] Accurately measure 1mL of mulberry linoleic acid liposomes, disperse mulberry linoleic acid powder in water as a control, dilute to 5mL with distilled water, and then add 40mL of simulated gastric juice. Shake and digest at a rate of 120rpm / min in a 37℃ constant temperature shaker. Take samples at 0, 20, 40, 60, 80, 100, and 120min after adding simulated gastric juice, with a sampling volume of 2mL. Add 20μL of 5mol / L sodium hydroxide solution to inactivate pepsin. Mix simulated small intestinal fluid and simulated bile fluid in a ratio of 2:1. Add 50mL of digested material after 120min of simulated gastric digestion, and the total volume reaches 100mL. The digestion was shaken at 120 rpm / min in a 37°C constant temperature shaker. Samples were taken at 0, 20, 40, 60, 80, 100, and 120 min after the addition of simulated intestinal fluid. The sample volume was 2 mL. 20 μL of 5 mol / L sodium hydroxide solution was added and the pH was adjusted to about 7. The total phenol content in the sampled solution was detected. The results are as follows: Figure 5 shown.
[0121] Figure 5 The release characteristics of mulberry linalool liposomes in simulated stomach and intestine were shown. Figure 5 It can be seen that the liposomes have well alleviated the release of mulberry yellow polyphenols in the stomach. About 9.8% of mulberry yellow polyphenols were released within 20 minutes after entering the stomach, and about 88.28% of the liposomes remained intact after 140 minutes. After the liposomes entered the intestine, they showed a rapid release phenomenon in the initial stage. This may be due to the action of bile and pancreatic enzymes in the simulated intestinal fluid, which caused a large amount of liposome leakage. After 140 minutes of entering the intestine, about 55.97% of the liposomes did not leak. The experimental results show that liposomes can delay the release of mulberry yellow polyphenols in the stomach and intestines, better maintain their own morphology, and thus improve bioavailability.
[0122] Experimental Example 3 Evaluation of in vivo release characteristics of mulberry linterus polyphenol liposomes
[0123] The in vivo release characteristics of liposomes were evaluated by an in situ intestinal ligation model in mice. The mice were randomly divided into 12 groups (n=3). Six groups were randomly selected as free drug groups, and the other six groups were selected as liposome groups. The mice were anesthetized, and after the small intestine was ligated, the sample was injected into one end of the small intestine. The liposome group was given liposomes with a drug loading of 10 mg, and the free group was given a water suspension of mulberry yellow polyphenols with the same volume and mass as the liposome group. At 0.5, 1, 2, 3, and 4 hours, one group from the free drug group and one group from the liposome group were killed by cervical dislocation, and the intestinal contents were taken out to determine the total phenol content. The results are as follows Figure 6 shown.
[0124] The process of intestinal absorption is complex and the quantification of bioavailability remains challenging. This experiment used the intestinal in situ ligation method to maintain the integrity of the intestine and better simulate the absorption process of liposomes in vivo.
[0125] like Figure 6 As shown, 0.5h after the sample was injected into the intestine, both the non-liposome-encapsulated mulberry polyphenol and the mulberry polyphenol liposome showed significant absorption effects compared with 0h, and the remaining mulberry polyphenol in the intestine were 86.1% and 80.55%, respectively; after 1h, the mulberry polyphenol liposomes had about 52.08% remaining, and the non-liposome-encapsulated mulberry polyphenol had about 74.01% remaining. The absorption effect of the mulberry polyphenol liposome was significantly better than that of the non-liposome-encapsulated mulberry polyphenol, and with the increase of time, the advantage of the intestinal absorption of the mulberry polyphenol liposome became more significant.
[0126] Experimental Example 4 Evaluation of tissue distribution of mulberry linterus polyphenol liposomes and determination of blood drug concentration
[0127] Fluorescently label the liposomes. Accurately weigh 0.5 mg of DiO cell membrane green fluorescent probe using an electronic balance, dissolve 0.5 mg of DiO in 1 mL of dimethyl sulfoxide at room temperature, and manually shake to promote dissolution. After complete dissolution, extract a certain amount of DiO solution and add it to the prepared liposomes to make the concentration of DiO 20 μg / mL. The mechanical oscillator oscillates at high speed in the second gear for 60 seconds to prepare DiO fluorescent liposomes.
[0128] 21 mice were randomly divided into 7 groups and given DiO-labeled liposomes at a gavage dose of 30 mg / kg. The mice were killed by cervical dislocation and the heart, liver, spleen, lung, and kidney were removed. The mice were rinsed with normal saline to remove the blood. A certain amount of each tissue sample was weighed, and the tissues were homogenized after adding PBS to prepare a 10% tissue homogenate. DiO solution of corresponding concentration was added to the blank tissue homogenate to prepare plasma samples containing DiO concentrations of 0.2, 0.1, 0.05, 0.025, and 0.01 μg / mL. The corresponding fluorescence intensity was measured, and a standard curve was established according to the relevant method, and the regression equation and correlation coefficient (R2) were calculated. The fluorescence intensity of each group of tissue homogenates was tested in the sample group, and the tissue distribution results are shown in the figure. Figure 7 As shown in (a) and (b).
[0129] Then fluorescently label the liposomes. Accurately weigh 0.5 mg of DiO cell membrane green fluorescent probe on an electronic balance, dissolve 0.5 mg of DiO in 1 mL of dimethyl sulfoxide at room temperature, and manually shake to promote dissolution. After complete dissolution, extract a certain amount of DiO solution and add it to the prepared liposomes to make the concentration of DiO 20 μg / mL. The mechanical oscillator oscillates at high speed in the second gear for 60 seconds to prepare DiO fluorescent liposomes.
[0130] 21 mice were randomly divided into 7 groups and given DiO-labeled liposomes at an intragastric dose of 30 mg / kg. Blood was collected at 0, 0.5, 1, 2, 4, 8, and 12 h, placed in an anticoagulant centrifuge tube, and centrifuged at 6000 r / min for 15 min. The supernatant plasma was taken. DiO solution of corresponding concentration was added to blank plasma to prepare plasma samples containing DiO concentrations of 0.2, 0.1, 0.05, 0.025, and 0.01 μg / mL. The corresponding fluorescence intensity was measured, and a standard curve was established according to relevant methods, and the regression equation and correlation coefficient (R2) were calculated. The sample group detected the plasma fluorescence intensity of each group, and the results are shown as follows: Figure 7 As shown in (c).
[0131] Depend on Figure 7 As shown in (a) and (b), about 2 hours after intragastric administration of fluorescently labeled mulberry linterus polyphenol liposomes, the fluorescence intensity of liver and kidney reached a peak value, and the AUC of liver was 541.9±5.05, which was significantly higher than that of heart (AUC was 44.77±2.27), spleen (AUC was 106.7±3.42), lung (AUC was 40.07±2.92) and kidney (AUC was 155.9±4.22). Figure 5 As shown in (c), about 4 hours after intragastric administration of fluorescently labeled mulberry linterus polyphenol liposomes, the drug content in the blood reached a peak value, with an AUC of 131.1±2.94.
[0132] Experimental Example 5 Inhibitory Effect of Phellinus Immature Polyphenol Liposomes on Tumor Cells in H22 Tumor-Bearing Mice
[0133] Animal Experiment Design:
[0134] All mice were fed and watered freely under SPF conditions (12 h of light and 12 h of darkness per day, the temperature of the breeding environment was maintained at 23 ± 3 °C, and the relative humidity was 50-60%). After one week of adaptive breeding, 0.2 mL of H22 cells (5 × 10 7 cells / ml) to induce transplanted tumors. After tumor formation, the mice with successful tumor formation were randomly divided into 8 groups (10 mice in each group): (1) Model group: given distilled water; (2) Positive group: given 5-fluorouracil (5-FU) 20 mg / kg b.w.; (3) High-dose mulberry polyphenol group (PV5-H): given mulberry polyphenol 300 mg / kg b.w.; (4) Medium-dose mulberry polyphenol group (PV5-M): given mulberry polyphenol 200 mg / kg b.w.; (5) Low-dose mulberry polyphenol group (PV5-L): given mulberry polyphenol 100 mg / kg b.w.; (6) High-dose mulberry polyphenol liposome group (PV5-L-PV5-H-PV5-M-PV5-M-PV5-L ... H): administered with 300 mg / kg b.w. of mulberry linden polyphenol liposomes; (7) medium-dose group of mulberry linden polyphenol liposomes (L-PV5-M): administered with 200 mg / kg b.w. of mulberry linden polyphenol liposomes; (8) low-dose group of mulberry linden polyphenol liposomes (L-PV5-L): administered with 100 mg / kg b.w. of mulberry linden polyphenol liposomes; 10 mice of the same age were selected as the blank group (Control) and administered with distilled water; 10 mice of the same age were selected as the safety group (safe) and administered with 300 mg / kg b.w. of mulberry linden polyphenol liposomes. Body weight was measured and recorded daily. The results are shown in the table below. Figure 8 As shown in (b); observe whether the treatment leads to death during the experiment. After 21 days of continuous administration, the mice were killed, and blood, heart, liver, spleen, lung, kidney and tumor were collected, weighed and photographed. 2 / 2 calculated tumor volume, tumor tissue image such as Figure 8 As shown in (a), tumor weight Figure 8 (c) shows the tumor volume growth curve. Figure 8 As shown in (d).
[0135] Depend on Figure 8It can be seen that the weight of mice in the model group increased rapidly, L-PV5-L, L-PV5-M and L-PV5-H had no significant effect on the weight of H22 tumor-bearing mice, and the weight of the PV5-L, PV5-M and PV5-H groups increased faster than that of the control group. In addition, there was no difference in the mental state of mice in the Safe group compared with the Control group, indicating that L-PV5 had no obvious toxicity. The tumor volume and weight of the model group increased rapidly. Except for the PV5-L group, the tumor volume and weight of each treatment group were significantly reduced, especially in the L-PV5-H group, which was second only to the positive control group. At the same dose, the tumor volume and weight of the L-PV5 treatment group were significantly lower than those of the PV5 treatment group, indicating that L-PV5 has a better therapeutic effect.
[0136] The tumor tissue was fixed with 10% formalin, embedded in paraffin, and cut into paraffin tissue slices. The results were observed visually under a microscope. Fig. 9 As shown in (a). H&E staining and immunohistochemical analysis were performed. ImageJ software (NIH) was used to quantitatively measure the positive area. Fig. 9 (b) as shown.
[0137] Blood samples were collected from mice and centrifuged after 2 hours of storage. Serum samples were then collected. According to the instructions of the kit, hematological parameters such as alanine aminotransferase (glutamicpyruvic transaminase, GOT), aspartate aminotransferase (glutamicoxaloacetic transaminase, GPT), glutathione (Glutathione, GSH) and malondialdehyde (Malondialdehyde, MDA) in serum samples were measured. The levels of GSH and MDA in serum, the levels of GOT in serum, and the levels of GPT in serum were as follows: Fig. 9 As shown in (c), (d) and (e).
[0138] Depend on Fig. 9 As shown in (a), the tumor cells in the Model group have complete structure, neat arrangement, obvious mitosis, and a proliferative environment, while some tumor cells in the treatment group have nuclear condensation, enlarged cytoplasm, and fatty degeneration. Comparing the tumor inhibition effect, HE staining showed that the tumor necrosis area in the treatment group was significantly larger than that in the model group; Fig. 9In (b), the tumor necrosis area of the PV5-L group was 40.26±3.3%, the tumor necrosis area of the PV5-M group was 52.41±4.8%, the tumor necrosis area of the PV5-H group was 57.93±5.1%, the tumor necrosis area of the L-PV5-L group was 60.89±4.2%, the tumor necrosis area of the L-PV5-M group was 64.1±5.3%, and the tumor necrosis area of the L-PV5-H group was 71.2±4.6%. The results showed that PV5 has good anti-tumor activity in vivo, and liposome encapsulation enhances the anti-tumor effect of PV5; Fig. 9 As shown in (c), there was no significant difference in the levels of GSH and MDA in the serum of mice in the Control group and the Safe group. This result indicates that PV5 does not cause damage to the body. Fig. 9 (d) and 9(e), it can be seen that PV5 treatment can significantly reduce the levels of GOT and GPT in mice in a dose-dependent manner, and the effect of PV5 liposomes is better than PV5 at the same dose.
[0139] After the mouse tumor was collected, RNA was extracted from each group, the concentration of the obtained RNA was measured, and 1 μg RNA was taken for reverse transcription reaction. The reaction conditions were 25℃, 10min; 48℃, 40min; 95℃, 5min; 4℃. The obtained cDNA was used as a template for q-PCR quantitative analysis. Table 4 shows the required primer sequences. The reaction program is 50℃, 2min, 95℃, 10min, 1cycle, 95℃, 15s, 60℃, 1min, 40cycles. The results were processed by the ΔΔCT method to obtain the data.
[0140] Table 4 q-PCR primer sequences
[0141]
[0142] The data were expressed as mean ± standard deviation, and GraphPad Prism 7 software was used for statistical analysis. One-way analysis of variance was used to compare the significance of differences among the groups. P < 0.05 indicated that the difference was significant. Fig.10 shown.
[0143] In the apoptosis pathway, Bcl-2 family proteins control the permeability of the mitochondrial outer membrane by regulating membrane potential. Bcl-2 family proteins play a key role in regulating the release of mitochondrial-related apoptotic factors. When receiving apoptotic signals, Bax will relocate to the mitochondrial surface, forming pores across the mitochondrial membrane on the surface, resulting in a decrease in membrane potential, increased membrane permeability, and the release of pro-apoptotic factors such as Cytochrome c in the mitochondria into the cytoplasm, activating the Caspase protein family, such as Caspase-3, Caspase-8 and Caspase-9, ultimately leading to cell apoptosis or even cell death.
[0144] Depend on Fig.10 As shown in (a) to (d), compared with the Model group, the mRNA expression of Caspase-3, Caspase-8, Caspase-9, and Bax in the mouse tumor after intragastric administration of PV5 and PV5 liposomes was significantly increased in a dose-dependent manner, and the mRNA expression of the PV5 liposome treatment group was higher than that of the PV5 treatment group at the same dose. These results indicate that PV5 can significantly improve its therapeutic effect and promote tumor cell apoptosis after being encapsulated in liposomes.
[0145] The EGFR / MEK / ERK signaling pathway is the main pathway in the development of liver cancer. This pathway actively regulates cell proliferation, survival, migration, and metabolism. It also plays a key role in regulating the tumor microenvironment through angiogenesis and recruitment of inflammatory cells, and is closely related to tumor treatment response and metastasis. Fig.11 (a) to (b) show that in the experimental results, after PV5 treatment, the expression of ERBB1 and ERBB2 in the EGF receptor family in mouse tumors was significantly reduced. Previous studies have shown that the EGF receptor family can play a regulatory role in a variety of malignant tumors by activating the MEK / ERK signaling pathway. It is speculated that PV5 may significantly inhibit the expression of EGF receptor family proteins, leading to the inactivation of the downstream MEK / ERK signaling pathway, and effectively reduce the malignancy of liver cancer cells by inducing cell apoptosis and inhibiting cell proliferation. Fig.11 (c) to (d) show that PV5 can significantly inhibit the protein expression of phosphorylated MEK and phosphorylated ERK. Therefore, PV5 may inhibit the occurrence and development of liver cancer and promote cell apoptosis through the MEK / ERK pathway regulated by the EGF receptor family.
[0146] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.
Claims
1. A method for preparing mulberry linterus polyphenols, It is characterized in that The steps include: The fruiting bodies of Phellinus linteus were crushed, the obtained powder was mixed with an alcohol solution, ultrasonically extracted and centrifuged, and the supernatant was collected; removing the alcohol solution from the supernatant, and freeze-drying the supernatant after removing the alcohol solution to obtain the alcohol extract of Phellinus linteus fruiting body; Mixing and dissolving the ethanol extract of Phellinus linteus fruiting bodies with a volume fraction of 20% ethanol solution to obtain a suspension; Extracting the suspension with an organic reagent, collecting the extract to obtain a mixed extract; The organic reagent in the mixed extract is removed to obtain the mulberry linterus polyphenol extract.
2. The preparation method according to claim 1, It is characterized in that The alcohol solution is ethanol, the volume fraction of the ethanol is 60%, the solid-liquid ratio of the powder to the ethanol is 1g:20mL; the power of the ultrasonic extraction is 600W.
3. The preparation method according to claim 1, It is characterized in that The organic reagent includes petroleum ether, chloroform and ethyl acetate.
4. A method for preparing mulberry linterus polyphenol liposomes, It is characterized in that The steps include: Mixing the mulberry linseed polyphenols, cholesterol, soybean lecithin and an organic solvent to obtain a mixed solution; Recovering the organic solvent in the mixed solution to form a thin film of the remaining solution; Adding PBS solution to the film to obtain a light yellow aqueous solution; homogenizing the light yellow aqueous solution at room temperature and high pressure for 5 to 10 minutes to obtain the mulberry linalool liposome; The mulberry linseed polyphenols include the mulberry linseed polyphenols prepared by the preparation method according to any one of claims 1 to 3.
5. The preparation method according to claim 4, It is characterized in that The mass ratio of mulberry ignia polyphenol, cholesterol and soybean lecithin is 5-10:30-50:1-5, the concentration of soybean lecithin is 20 mg / mL, the concentration of mulberry ignia polyphenol is 2 mg / mL, and the concentration of cholesterol is 2.5 mg / mL.
6. The preparation method according to claim 4, It is characterized in that The organic solvent is one or more of anhydrous ethanol, ether and chloroform, and the total mass of the mulberry linterin, cholesterol and soybean lecithin and the solid-liquid ratio of the organic solvent is 1g:10-50mL. 。 7. The preparation method according to claim 4, It is characterized in that The material-liquid ratio of the PBS solution to the film is 1 g: 10-50 mL; After the PBS solution is added to the film, the film is further dispersed by rotation and ultrasound; The temperature of the rotation is 40° C., the time of the ultrasonic dispersion is 30 min; and the pressure of the high-pressure homogenization is 1200 MPa.
8. A mulberry linterus polyphenol liposome, It is characterized in that The method is obtained by any one of claims 4 to 7.
9. The method for preserving the mulberry linolenic acid liposome according to claim 8, It is characterized in that The mulberry linterus polyphenol liposomes are stored at 4-25° C. in the dark.
10. Use of the method for preparing mulberry linden polyphenols according to any one of claims 1 to 3, the method for preparing mulberry linden polyphenol liposomes according to any one of claims 4 to 7, the mulberry linden polyphenol liposomes according to claim 8 or the preservation method according to claim 9 in the preparation of one or more of anti-tumor drugs, antioxidant drugs and anti-inflammatory drugs.
Citation Information
Patent Citations
Phellinus igniarius extract liposome with high bioavailability as well as preparation method and application of phellinus igniarius extract liposome
CN116549391A
